questionsmedicales.fr
Infection
Maladies virales
Infections à virus à ARN
Fièvres hémorragiques virales
Fièvres hémorragiques virales : Questions médicales fréquentes
Diagnostic
5
Fièvres hémorragiques
Diagnostic médical
Tests de laboratoire
Fièvres hémorragiques
Symptômes
Fièvres hémorragiques
Épidémiologie
Fièvres hémorragiques
Fièvres hémorragiques
Tests de laboratoire
Symptômes
5
Symptômes
Fièvres hémorragiques
Virus
Fièvres hémorragiques
Diagnostic médical
Fièvres hémorragiques
Évolution de la maladie
Fièvres hémorragiques
Prévention
5
Prévention
Fièvres hémorragiques
Vaccins
Fièvres hémorragiques
Contrôle des infections
Fièvres hémorragiques
Traitements
5
Traitement
Fièvres hémorragiques
Antibiotiques
Fièvres hémorragiques
Antiviraux
Fièvres hémorragiques
Complications
5
Complications
Fièvres hémorragiques
Complications
Fièvres hémorragiques
Pronostic
Fièvres hémorragiques
Séquelles
Fièvres hémorragiques
Facteurs de risque
5
Facteurs de risque
Fièvres hémorragiques
Travailleurs de la santé
Fièvres hémorragiques
Immunodépression
Fièvres hémorragiques
Enfants
Fièvres hémorragiques
Environnement
Fièvres hémorragiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fièvres hémorragiques virales : Questions médicales les plus fréquentes",
"headline": "Fièvres hémorragiques virales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fièvres hémorragiques virales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-13",
"dateModified": "2026-02-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fièvres hémorragiques virales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à virus à ARN",
"url": "https://questionsmedicales.fr/mesh/D012327",
"about": {
"@type": "MedicalCondition",
"name": "Infections à virus à ARN",
"code": {
"@type": "MedicalCode",
"code": "D012327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dengue",
"alternateName": "Dengue",
"url": "https://questionsmedicales.fr/mesh/D003715",
"about": {
"@type": "MedicalCondition",
"name": "Dengue",
"code": {
"@type": "MedicalCode",
"code": "D003715",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.214"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dengue sévère",
"alternateName": "Severe Dengue",
"url": "https://questionsmedicales.fr/mesh/D019595",
"about": {
"@type": "MedicalCondition",
"name": "Dengue sévère",
"code": {
"@type": "MedicalCode",
"code": "D019595",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.214.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Fièvre hémorragique avec syndrome rénal",
"alternateName": "Hemorrhagic Fever with Renal Syndrome",
"url": "https://questionsmedicales.fr/mesh/D006480",
"about": {
"@type": "MedicalCondition",
"name": "Fièvre hémorragique avec syndrome rénal",
"code": {
"@type": "MedicalCode",
"code": "D006480",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fièvre hémorragique américaine",
"alternateName": "Hemorrhagic Fever, American",
"url": "https://questionsmedicales.fr/mesh/D006478",
"about": {
"@type": "MedicalCondition",
"name": "Fièvre hémorragique américaine",
"code": {
"@type": "MedicalCode",
"code": "D006478",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fièvre hémorragique de Crimée-Congo",
"alternateName": "Hemorrhagic Fever, Crimean",
"url": "https://questionsmedicales.fr/mesh/D006479",
"about": {
"@type": "MedicalCondition",
"name": "Fièvre hémorragique de Crimée-Congo",
"code": {
"@type": "MedicalCode",
"code": "D006479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.412"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fièvre hémorragique d'Omsk",
"alternateName": "Hemorrhagic Fever, Omsk",
"url": "https://questionsmedicales.fr/mesh/D006481",
"about": {
"@type": "MedicalCondition",
"name": "Fièvre hémorragique d'Omsk",
"code": {
"@type": "MedicalCode",
"code": "D006481",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.435"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de la forêt Kyasanur",
"alternateName": "Kyasanur Forest Disease",
"url": "https://questionsmedicales.fr/mesh/D007733",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de la forêt Kyasanur",
"code": {
"@type": "MedicalCode",
"code": "D007733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.475"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fièvre de Lassa",
"alternateName": "Lassa Fever",
"url": "https://questionsmedicales.fr/mesh/D007835",
"about": {
"@type": "MedicalCondition",
"name": "Fièvre de Lassa",
"code": {
"@type": "MedicalCode",
"code": "D007835",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.505"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fièvre jaune",
"alternateName": "Yellow Fever",
"url": "https://questionsmedicales.fr/mesh/D015004",
"about": {
"@type": "MedicalCondition",
"name": "Fièvre jaune",
"code": {
"@type": "MedicalCode",
"code": "D015004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417.881"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Fièvres hémorragiques virales",
"alternateName": "Hemorrhagic Fevers, Viral",
"code": {
"@type": "MedicalCode",
"code": "D006482",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jessica R Spengler",
"url": "https://questionsmedicales.fr/author/Jessica%20R%20Spengler",
"affiliation": {
"@type": "Organization",
"name": "Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."
}
},
{
"@type": "Person",
"name": "Masayuki Saijo",
"url": "https://questionsmedicales.fr/author/Masayuki%20Saijo",
"affiliation": {
"@type": "Organization",
"name": "Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Christina F Spiropoulou",
"url": "https://questionsmedicales.fr/author/Christina%20F%20Spiropoulou",
"affiliation": {
"@type": "Organization",
"name": "Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."
}
},
{
"@type": "Person",
"name": "Éric Bergeron",
"url": "https://questionsmedicales.fr/author/%C3%89ric%20Bergeron",
"affiliation": {
"@type": "Organization",
"name": "Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA ebergeron@cdc.gov."
}
},
{
"@type": "Person",
"name": "Ali Mirazimi",
"url": "https://questionsmedicales.fr/author/Ali%20Mirazimi",
"affiliation": {
"@type": "Organization",
"name": "Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Alfred Nobels Alle 8 Plan 7, Stockholm 14183, Sweden."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38905317",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0305521"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses].",
"datePublished": "2023-11-29",
"url": "https://questionsmedicales.fr/article/38018929",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1051/medsci/2023162"
}
},
{
"@type": "ScholarlyArticle",
"name": "Understanding the delay in identifying Sudan Virus Disease: gaps in integrated disease surveillance and response and community-based surveillance to detect viral hemorrhagic fever outbreaks in Uganda, September 2022.",
"datePublished": "2024-07-30",
"url": "https://questionsmedicales.fr/article/39080599",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-024-09659-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Community knowledge, attitude and practices regarding zoonotic viral haemorrhagic fevers in five geo-ecological zones in Tanzania.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37046281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-023-09317-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38749416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1088/1758-5090/ad4c0b"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fièvres hémorragiques virales",
"item": "https://questionsmedicales.fr/mesh/D006482"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fièvres hémorragiques virales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fièvres hémorragiques virales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fièvres hémorragiques virales",
"description": "Comment diagnostiquer une fièvre hémorragique virale ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels symptômes initiaux indiquent une fièvre hémorragique ?\nQuand faut-il suspecter une fièvre hémorragique ?\nLes tests de dépistage sont-ils fiables ?",
"url": "https://questionsmedicales.fr/mesh/D006482#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fièvres hémorragiques virales",
"description": "Quels sont les symptômes principaux des fièvres hémorragiques ?\nLes symptômes varient-ils selon le virus ?\nY a-t-il des symptômes tardifs à surveiller ?\nLes symptômes sont-ils similaires à d'autres maladies ?\nComment évoluent les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D006482#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fièvres hémorragiques virales",
"description": "Comment prévenir les fièvres hémorragiques virales ?\nLes vaccins existent-ils pour ces maladies ?\nQuelles mesures de contrôle des infections sont recommandées ?\nComment se protéger lors de voyages en zones à risque ?\nLes moustiquaires sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D006482#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fièvres hémorragiques virales",
"description": "Quel est le traitement principal des fièvres hémorragiques ?\nLes antibiotiques sont-ils efficaces ?\nComment gérer les hémorragies ?\nY a-t-il des antiviraux disponibles ?\nQuel rôle joue l'hydratation dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D006482#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fièvres hémorragiques virales",
"description": "Quelles sont les complications possibles ?\nLes complications sont-elles fréquentes ?\nComment les complications affectent-elles le pronostic ?\nY a-t-il des séquelles après guérison ?\nLes complications varient-elles selon le virus ?",
"url": "https://questionsmedicales.fr/mesh/D006482#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fièvres hémorragiques virales",
"description": "Quels sont les principaux facteurs de risque ?\nLes travailleurs de la santé sont-ils à risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLes enfants sont-ils plus à risque ?\nComment l'environnement influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006482#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une fièvre hémorragique virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et PCR pour identifier le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques, PCR et cultures virales sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes initiaux indiquent une fièvre hémorragique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs musculaires, fatigue et maux de tête sont des symptômes initiaux."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une fièvre hémorragique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de voyage dans des zones endémiques et de symptômes compatibles."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils fiables ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais leur fiabilité dépend du moment du test et du virus suspecté."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux des fièvres hémorragiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, hémorragies, douleurs abdominales et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques et des sévérités différentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes tardifs à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de choc, défaillance organique et hémorragies sévères peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à d'autres maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent ressembler à ceux de la dengue ou de la grippe, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver rapidement, nécessitant une surveillance étroite."
}
},
{
"@type": "Question",
"name": "Comment prévenir les fièvres hémorragiques virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les contacts avec des personnes infectées et utiliser des mesures de protection."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour ces maladies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins sont disponibles pour certaines fièvres hémorragiques comme la fièvre jaune."
}
},
{
"@type": "Question",
"name": "Quelles mesures de contrôle des infections sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement des patients, désinfection et protection du personnel médical sont essentielles."
}
},
{
"@type": "Question",
"name": "Comment se protéger lors de voyages en zones à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des répulsifs, porter des vêtements longs et éviter les contacts avec les animaux."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles aident à prévenir les piqûres d'insectes, réduisant le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des fièvres hémorragiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique, le soutien symptomatique est essentiel."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment gérer les hémorragies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transfusion de plaquettes et de plasma peut être nécessaire en cas d'hémorragies sévères."
}
},
{
"@type": "Question",
"name": "Y a-t-il des antiviraux disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antiviraux sont en étude, mais aucun n'est encore approuvé pour un usage général."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hydratation dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour prévenir la déshydratation et soutenir la fonction organique."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choc hypovolémique, défaillance organique et hémorragies internes sont des complications graves."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles surviennent souvent chez les patients gravement atteints."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles le pronostic ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications augmentent le risque de mortalité et nécessitent une prise en charge rapide."
}
},
{
"@type": "Question",
"name": "Y a-t-il des séquelles après guérison ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent éprouver des séquelles neurologiques ou psychologiques."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le virus ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut entraîner des complications spécifiques et des taux de mortalité différents."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des zones endémiques, contact avec des animaux infectés et exposition à des fluides corporels."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont exposés lors de soins aux patients infectés sans protection adéquate."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles courent un risque accru de complications graves en cas d'infection."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent être plus vulnérables aux complications sévères de certaines fièvres."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conditions environnementales comme l'humidité et la chaleur favorisent la transmission des virus."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/02/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Publications dans "Fièvres hémorragiques virales" :
3 publications dans cette catégorie
Affiliations :
Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Publications dans "Fièvres hémorragiques virales" :
3 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publications dans "Fièvres hémorragiques virales" :
3 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA ebergeron@cdc.gov.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Alfred Nobels Alle 8 Plan 7, Stockholm 14183, Sweden.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Institute of Biology, University of Szczecin, Felczaka 3c, 71-412 Szczecin, Poland.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Maria G. Frank, MD, is Medical Director, Biocontainment Unit, Department of Medicine; and.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada; Interdepartmental Division of Critical Care, University of Toronto, 209 Victoria Street, 4th Floor, Room 411, Toronto, Ontario M5B 1T8, Canada.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Service de médecine interne et maladies infectieuses, Centre hospitalier de Kiffa, Assaba, Mauritanie.
Burkina Field Epidemiology and Laboratory Training Program. Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Galveston National Laboratory and.
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, USA.
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Publications dans "Fièvres hémorragiques virales" :
2 publications dans cette catégorie
Publications dans "Fièvres hémorragiques virales" :
There have been several Viral Hemorrhagic Fever (VHF) outbreaks in Nigeria which remains a public health concern. Despite the increasing number of suspected cases of VHF due to heightened surveillance...
Arenaviruses are a global threat, causing thousands of deaths each year in several countries around the world. Despite strong efforts in the development of vaccine candidates, vaccines against Lassa f...
Early detection of outbreaks requires robust surveillance and reporting at both community and health facility levels. Uganda implements Integrated Disease Surveillance and Response (IDSR) for priority...
Using a standardized tool, we evaluated core surveillance capacities at public and private health facilities at the hospital level and below in three sub-counties reporting the earliest SVD cases in t...
Forty-six (85%) of 54 health facilities surveyed were privately-owned, among which 42 (91%) did not report to DHIS2 and 39 (85%) had no health worker trained on IDSR; both metrics were 100% in the eig...
Both systemic and knowledge-related gaps in IDSR surveillance in SVD-affected districts contributed to the delayed detection of the 2022 Uganda SVD outbreak. Targeted interventions to address these ga...
Viral haemorrhagic fevers (VHF) cause significant economic and public health impact in Sub-Saharan Africa. Community knowledge, awareness and practices regarding such outbreaks play a pivotal role in ...
A cross-sectional study was conducted in Buhigwe, Kalambo, Kyela, Kinondoni, Kilindi, Mvomero, Kondoa and Ukerewe districts representing five geo-ecological zones in Tanzania. Study participants were ...
A total of 2,965 individuals were involved in the study. Their mean age was 35 (SD ± 18.9) years. Females accounted for 58.2% while males 41.8%. Most of the respondents (70.6%; n = 2093) had never hea...
Overall, the knowledge on VHF among communities is low, while a large proportion of individuals in the community are involved in activities that expose them to the disease pathogens in Tanzania. These...
The hemorrhagic fever viruses (HFV) cause severe or fatal infections in humans. Named after their common symptom hemorrhage, these viruses induce significant vascular dysfunction by affecting endothel...
Assay validation is an essential component of disease surveillance testing, but can be problematic in settings where access to positive control material is limited and a safety risk for handlers. Here...
The Sudan virus disease outbreak in 2022 prompted the Denver Health High-Risk Infection Team (HITeam) to evaluate and implement novel strategies to respond to viral hemorrhagic fever (VHF) events. To ...
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease caused by the CCHF virus. It was first recognized in 1944 in the Crimea region of the former Soviet Union and then was subsequently isolate...
Viral hemorrhagic fevers (VHFs), such as Ebola virus disease, Marburg virus disease, and Lassa fever, are associated with significant morbidity and mortality and the potential for person-to-person tra...
To improve laboratory preparedness and readiness in the initial care of suspect VHF patients who may present to acute care hospitals....
Plan-Do-Study-Act quality improvement model....
Frontline healthcare facilities and their clinical laboratories....
We describe the development of a laboratory testing toolkit for a suspect VHF patient that can assist frontline HCFs in providing basic laboratory testing required for the care of these patients....
The toolkit provides guidance on infection prevention and control, waste management, occupational health, laboratory test collection, processing, and resulting, in the context of suspect VHF patient e...
The toolkit is designed to be readily adapted by any frontline HCF in the US. With the guidance provided, facilities will be able to support safer initial evaluation of VHF suspects and ensure high-qu...
Crimean-Congo hemorrhagic fever virus (CCHFV) is a priority pathogen transmitted by tick bites, with no vaccines or specific therapeutics approved to date. Severe disease manifestations include hemorr...